phase 1_initiation
saveGan & Lee Pharmaceuticals Co Ltd — GLR-2037 (Phase I Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Prostate Cancer
Data sources
globaldata
Found something off?
same company · ±60 days · 2
- phase 3 initiation(insulin aspart + insulin aspart protamine): Gan & Lee Pharmaceuticals Co Ltd — (insulin aspart + insulin aspart protamine) (Phase III Trial Initiation)Apr 29, 2026
- phase 3 initiationbofanglutide: Gan & Lee Pharmaceuticals Co Ltd — bofanglutide (Phase III Trial Initiation)Apr 27, 2026
comments(0)
5-min edit window · permanent after that